Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Breast Cancer Research2005Vol. 7(6), pp. R953–64
Citations Over TimeTop 10% of 2005 papers
Yudi Pawitan, Judith Bjöhle, Lukas C. Amler, Anna-Lena Borg, Suzanne Egyházi, Per Hall, Xia Han, Lars Holmberg, Fei Huang, Sigrid Klaar, Edison T. Liu, Lance D. Miller, Hans Nordgren, Alexander Ploner, Kerstin Sandelin, Peter Shaw, Johanna Smeds, Lambert Skoog, Sara Wedrén, Jonas Bergh
Abstract
We have identified discriminatory gene expression signatures working both on untreated and systematically treated primary breast cancer patients with the potential to spare them from adjuvant therapy.
Related Papers
- → Society of Surgical Oncology SSO 2023 - International Conference on Surgical Cancer Care(2023)3 cited
- → ASO Author Reflections: Investigating the Relationship Between Patient Primary Language and Surgical Oncology Outcomes(2022)1 cited
- → Controversies in Gynaecologic Oncology(2017)1 cited
- → Abstracts exchange: European Journal of Surgical Oncology(1996)
- → ASO Visual Abstract: Application and Match Rates in the Complex General Surgical Oncology Match(2022)